![](https://webarchive.library.unt.edu/eot2008/20081011165756im_/http://www.nci.nih.gov/images/spacer.gif) |
¿Preguntas sobre el cáncer?
![](https://webarchive.library.unt.edu/eot2008/20081011165756im_/http://www.nci.nih.gov/images/spacer.gif)
|
1-800-422-6237
(1-800-4-CANCER)
|
![](https://webarchive.library.unt.edu/eot2008/20081011165756im_/http://www.nci.nih.gov/images/spacer.gif)
|
Llame de lunes a viernes de 9:00 a.m. a 4:30 p.m., hora local en Estados Unidos y sus territorios. |
|
![](https://webarchive.library.unt.edu/eot2008/20081011165756im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081011165756im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081011165756im_/http://www.nci.nih.gov/images/spacer.gif)
| Proteína en estudio para el tratamiento de cáncer. Las sustancias que se unen al CD134 en la superficie de las células T (tipo de glóbulo blanco) pueden ayudar a las células T a que crezcan y destruyan más células cancerosas. CD134 es un tipo de receptor del factor de necrosis tumoral (FNT). También se llama OX-40. |
![](https://webarchive.library.unt.edu/eot2008/20081011165756im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081011165756im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081011165756im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081011165756im_/http://www.nci.nih.gov/images/spacer.gif) |